Dual stellate ganglion block reduces symptoms in treatment-resistant anxiety trial in Chickballapur
Topic: generalRegion: asia pacificUpdated: i1 outletsSources: 1Spectrum: Center Only⏱ 1 min read⚠ 3d+ old
Story Summary
SITUATION
Doctors at Sri Madhusudan Sai Institute of Medical Sciences and Research performed a dual stellate ganglion block and found it produced a significantly greater reduction in anxiety symptoms than a sham procedure in 63 patients. The trial, led by G.
Coveragetap to expand ▾Spectrum: Center Only🌍Asia: 1
Political Spectrum
Position is inferred from coverage mix.
i1 outlets · Center
Left
Center
Right
Left: 0
Center: 1
Right: 0
Geography Coverage
Distribution of where coverage is coming from.
i1 unique outlets · Dominant: Asia
KEY FACTS
- Patients who underwent dual stellate ganglion block (SGB) had a significantly greater reduction in anxiety symptoms than those who received a sham procedure.
- The trial was led by G. Niraj, senior consultant, anaesthesiology, with a multidisciplinary team of Pain Medicine physicians, psychiatrists, and clinical psychologists.
- Researchers claim this is the world’s first randomized controlled trial evaluating dual SGB specifically for treatment-resistant anxiety.
- The study was published in the July-August 2026 issue of Pain Physician, an open-access journal.
HISTORICAL CONTEXT
—
Brief
Doctors at Sri Madhusudan Sai Institute of Medical Sciences and Research tested a dual stellate ganglion block (SGB) and found it produced a significantly greater reduction in anxiety symptoms than a sham procedure in 63 patients. The researchers say this is the world’s first randomised controlled trial of dual SGB for treatment-resistant anxiety and published the results in Pain Physician.
Sources
1 of 1 linked articles